MoneyWorks4Me

Supriya Lifescience - Quaterly Results

26 May 2023 Evaluate
The sales is pegged at Rs. 1422.70 millions for the March 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 1812.69 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 382.29  millions from Rs. 462.12 millions ,decline by -17.27%.A decline of 570.10 millions was observed in the OP in the quarter ended March 2023 from 790.78 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1422.70 1812.69 -21.51 4609.38 5300.49 -13.04 4609.38 5300.49 -13.04
Other Income 19.64 38.55 -49.05 94.89 75.77 25.23 94.89 75.77 25.23
PBIDT 570.10 790.78 -27.91 1383.87 2215.62 -37.54 1383.87 2215.62 -37.54
Interest 7.14 10.17 -29.79 30.84 41.98 -26.54 30.84 41.98 -26.54
PBDT 562.96 780.61 -27.88 1353.03 2173.64 -37.75 1353.03 2173.64 -37.75
Depreciation 30.07 25.79 16.60 118.15 101.18 16.77 118.15 101.18 16.77
PBT 532.89 754.82 -29.40 1234.88 2072.46 -40.41 1234.88 2072.46 -40.41
TAX 150.60 292.70 -48.55 336.30 554.35 -39.33 336.30 554.35 -39.33
Deferred Tax 18.53 108.25 -82.88 29.49 32.46 -9.15 29.49 32.46 -9.15
PAT 382.29 462.12 -17.27 898.58 1518.11 -40.81 898.58 1518.11 -40.81
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 40.07 43.62 -8.14 30.02 41.80 -28.18 30.02 41.80 -28.18
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..